期刊： JAMA PSYCHIATRY, 2021; 78 (7)
IMPORTANCE The ENIGMA clinical high risk (CHR) for psychosis initiative, the largest pooled neuroimaging sample of individuals at CHR to date, aims to......
期刊： JAMA PSYCHIATRY, 2021; 78 (9)
IMPORTANCE Animal studies have shown that the adolescent brain is sensitive to disruptions in endocannabinoid signaling, resulting in altered neurodev......
IMPORTANCE Antidepressants are commonly used to treat major depressive disorder (MDD). Antidepressant outcomes can vary based on individual difference......
期刊： JAMA PSYCHIATRY, 2021; 78 (1)
Importance Large-scale neuroimaging studies have revealed group differences in cortical thickness across many psychiatric disorders. The underlying ne......
期刊： JAMA PSYCHIATRY, 2021; 78 (4)
IMPORTANCE To date, the association of psychiatric diagnoses with mortality in patients infected with coronavirus disease 2019 (COVID-19) has not been......
期刊： JAMA PSYCHIATRY, 2020; 77 (6)
Key PointsQuestionCan a blood marker of epigenetic risk for schizophrenia be derived that is specific for the disease and predicts epigenetic changes ......
期刊： JAMA PSYCHIATRY, 2020; 77 (8)
Key PointsQuestionWhat proportion of patients with depression perceive treatment as helpful? FindingsThis study of 80332 respondents surveyed in 16 co......
期刊： JAMA PSYCHIATRY, 2020; 77 (11)
Key PointsQuestionIs chronic untreated psychosis associated with decreases in cognitive performance? FindingsIn this case-control study of 197 individ......
期刊： JAMA PSYCHIATRY, 2019; 76 (1)
IMPORTANCE Anxiety disorders are common in children and adolescents, and uncertainty remains regarding the optimal strategy of psychotherapies in this......
期刊： JAMA PSYCHIATRY, 2019; 76 (4)
IMPORTANCE Deviation from normal adolescent brain development precedes manifestations of many major psychiatric symptoms. Such altered developmental t......
期刊： JAMA PSYCHIATRY, 2019; 76 (8)
This cohort study assesses association of the type and age of exposure to childhood maltreatment with hyperactive and hypoactive amygdala responses in......
